ATOMIC Trial ASCO 2025: Key Findings on dMMR Stage III Colon Cancer Treatment
Автор: OncologyTube
Загружено: 2025-06-01
Просмотров: 664
Описание:
ARTICLE: https://oncologytube.com/atomic-trial...
Join us for an OncologyTube exclusive from ASCO 2025 in Chicago! This video covers the ATOMIC trial results presented at the plenary session on June 1, 2025. The phase III ATOMIC trial ASCO 2025 study compares atezolizumab plus mFOLFOX6 to mFOLFOX6 alone in 712 patients with stage III dMMR colon cancer. Key findings include a three-year DFS of 86.4% with atezolizumab versus 76.6% with mFOLFOX6 (HR 0.50, p 0.0001). Safety data and subgroup analysis are also discussed, showing consistent efficacy across low- and high-risk groups.
For a detailed written companion, visit OncologyTube.com: https://oncologytube.com/atomic-trial.... Explore more ASCO 2025 updates on our channel: https://oncologytube.com/tag/asco/.
Don’t forget to like, subscribe, and share for the latest in oncology research!
Timestamps:
0:00 – Introduction to ASCO 2025 and ATOMIC Trial
0:07 – ATOMIC Trial Overview
0:14 – Trial Design and Patient Distribution
0:27 – Patient Demographics
0:41 – Disease-Free Survival Results
0:54 – Statistical Significance
1:01 – Safety Data
1:09 – Subgroup Analysis
1:14 – Implications for dMMR Colon Cancer
1:26 – Closing and Call to Action
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
